Ascent PharmaTech Co., Ltd. 2025 Q4 Financials
Ascent PharmaTech Co., Ltd. reported a basic EPS of NTbash.90 for Q4 2025. The company's operating revenue reached NT.344 billion, with a net income after tax of NTbash.107 billion.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:20 (16h 20m after Collected)
Company Code: 4119 Company Name: Ascent PharmaTech Co., Ltd. Industry: Biotechnology and Medical Care Industry Year/Quarter: 2025 Q4 Basic Earnings Per Share (EPS): NTbash.90 Operating Revenue: NT.344 billion Net Income After Tax: NTbash.107 billion